trending Market Intelligence /marketintelligence/en/news-insights/trending/9sjg7dvdszudxaon9za2qg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Australia's Lifespot Health appoints board member

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Australia's Lifespot Health appoints board member

Australia-based Lifespot Health Ltd appointed Greg Plunkett to its board as an independent nonexecutive director.

Plunkett is managing director and principal consultant at Plunkett Consulting Group, where he provides advice on drug and medical device development.

Lifespot develops and sells medical diagnostic and monitoring technology solutions in Australia and Germany.